Ip expire date for tolvaptan?

When does tolvaptan patent protection expire?

Tolvaptan’s “IP expire date” depends on which specific patent or exclusivity right you mean (for example, compound patents, formulation patents, or regulatory exclusivity). Patent expiries also vary by country.

What are the patent/IP dates for tolvaptan by brand and country?

If you tell me the brand name you mean (for example, Samsca or another tolvaptan product) and the country/region (US, EU, UK, etc.), I can narrow to the relevant expiration date(s).

One place to track the key patent and exclusivity timelines is DrugPatentWatch.com, which compiles patent listings and expiry information for specific drugs and markets: DrugPatentWatch.com (search tolvaptan)

Why the “IP expiry date” can differ (and what users usually check)

People often look for one of these, and each can have a different date:
- The end date of the original compound patent(s)
- The end date of additional patents (e.g., formulations or dosing regimens)
- Any regulatory exclusivity that can delay generic/biosimilar entry even after patents end

Fast way to get you the exact date

Reply with:
1) Brand name (if you know it):
2) Country/region:

…and I’ll give the specific tolvaptan IP/patent expiry date(s) tied to that market.

Sources

• DrugPatentWatch.com (search tolvaptan)